1.Multifocal Electroretinogram Findings after Intravitreal Bevacizumab Injection in Choroidal Neovascularization of Age-Related Macular Degeneration.
Joo Youn PARK ; Seung Hoon KIM ; Tae Kwann PARK ; Young Hoon OHN
Korean Journal of Ophthalmology 2011;25(3):161-165
PURPOSE: To evaluate the changes in multifocal electroretinogram (mfERG) and optical coherence tomography (OCT) after intravitreal bevacizumab injection in the treatment of age-related macular degeneration (AMD). METHODS: Twenty-one eyes with choroidal neovascularization secondary to AMD were studied before and after intravitreal bevacizumab injection for best corrected visual acuity (BCVA), OCT, and mfERG. RESULTS: The BCVA improved, while central macular thickness and total macular volume in OCT decreased after intravitreal bevacizumab injection (p = 0.03, 0.01, and 0.01, respectively). In mfERG, the amplitude of P1, and implicit time of P1 and N1 indicated a statistically significant improvement of retinal response after intravitreal bevacizumab injection. CONCLUSIONS: There is a potential role for mfERG in evaluating the effect on retinal function of intravitreal bevacizumab injection.
Adult
;
Aged
;
Angiogenesis Inhibitors/*administration & dosage
;
Antibodies, Monoclonal/*administration & dosage
;
Choroidal Neovascularization/*drug therapy/*etiology
;
Electroretinography/*methods
;
Eyeglasses
;
Humans
;
Intravitreal Injections
;
Macular Degeneration/*complications/diagnosis/physiopathology
;
Middle Aged
;
Retina/drug effects/physiopathology
;
Tomography, Optical Coherence
;
Visual Acuity
2.The Anti-angiogenic Effect of Chlorogenic Acid on Choroidal Neovascularization.
Cinoo KIM ; Hyeong Gon YU ; Joonhong SOHN
Korean Journal of Ophthalmology 2010;24(3):163-168
PURPOSE: To evaluate the inhibitory effect of chlorogenic acid on laser-induced choroidal neovascularization (CNV) in a rat model. METHODS: Intraperitoneal injection of chlorogenic acid (10 mg/kg) was inititated one day prior to laser photocoagulation and continued for eight days. Eyes were removed 14 days after laser photocoagulation. Fluorescein angiography was employed at seven and 14 days to assess the CNV lesions, and histological examination was performed. Quantification of CNV size and leakage were performed both in histological sections and fluorescein angiography in order to compare the inhibitory effects of chlorogenic acid on CNV with the results of the control. RESULTS: Histological analysis showed no significant difference in CNV size between the treated and control groups. However, CNV leakage on fluorescein angiography had significantly decreased in the chlorogenic acid-treated group at 14 days after laser photocoagulation compared with that of the control group. In addition, CNV size on fluorescein angiography had significantly decreased in the treated group at seven and 14 days. CONCLUSIONS: These results suggest that chlorogenic acid has anti-angiogenic effects on CNV and may be useful as an inhibitor in the treatment or prevention of neovascular age-related macular degeneration.
Angiogenesis Inhibitors/*administration & dosage
;
Animals
;
Capillary Permeability/drug effects
;
Chlorogenic Acid/*administration & dosage
;
Choroid/pathology
;
Choroidal Neovascularization/diagnosis/etiology/*physiopathology
;
Fluorescein Angiography
;
Injections, Intraperitoneal
;
Laser Coagulation
;
Radiation Injuries
;
Rats
;
Rats, Inbred BN
3.The Development of Recurrent Choroidal Neovascularization in a Patient with Choroidal Coloboma.
Sun Ho LEE ; Jae Kyun AHN ; Hyeong Gon YU
Korean Journal of Ophthalmology 2011;25(1):63-65
We report a case of recurrent choroidal neovascularization (CNV) in an eye with chorioretinal coloboma. A 36-year-old woman presented complaining of decreased visual acuity (VA) in her left eye. Best corrected visual acuity (BCVA) was 20/200 and iris coloboma was observed. Funduscopy and fluorescein angiography (FA) showed CNV in the superior extrafoveal region with chorioretinal coloboma reaching just inferior to the optic disc. No other cause for CNV was observed except for the chorioretinal coloboma. BCVA improved to 20/30 after laser photocoagulation. She revisited our clinic for deteriorating VA (20/400) in the same eye 3 years after treatment. Funduscopy and FA demonstrated recurrent CNV with subfoveal hemorrhage. Photodynamic therapy (PDT) was followed by three consecutive intravitreal bevacizumab injections (IVB) for the subfoveally-located CNV. However, the CNV persisted with the appearance of a fresh subretinal hemorrhage. Additional PDT was combined with IVB on the same day 6 months after the initial PDT. The CNV regressed 3 months after treatment and has not recurred as of 8 months after the last treatment. The patient's BCVA improved to 20/60. This case suggests that PDT combined with IVB can be an alternative treatment for the management of recurrent CNV after laser photocoagulation in eyes with chorioretinal coloboma.
Adult
;
Angiogenesis Inhibitors/administration & dosage
;
Antibodies, Monoclonal/administration & dosage
;
Choroid Diseases/*complications/drug therapy/surgery
;
Choroidal Neovascularization/diagnosis/*etiology/physiopathology
;
Coloboma/*complications/drug therapy/surgery
;
Female
;
Fluorescein Angiography
;
Fundus Oculi
;
Humans
;
Intravitreal Injections
;
Laser Coagulation
;
Photochemotherapy
;
Recurrence
;
Visual Acuity